Main page content

Displaying results 1 - 6 of 6
Publication ID: PEP21-05-00-001
Published:

This document provides an overview of essential information necessary for understanding mental health and substance use disorder parity and how to implement and comply with federal parity laws. This guide applies to parity laws in employer-sponsored health plans and group and individual insurance.

Publication ID: PEP15-FEDGUIDEOTP
Published:

This manual provides guidelines for the operation of opioid treatment programs. It covers patient assessment, treatment planning, and recovery care. The manual also offers guidance for medication-assisted treatment for methadone and buprenorphine, and overdose and relapse prevention.

Publication ID: SMA14-4852
Published:

This guide highlights the use of medication-assisted treatment (MAT) for opioid use disorder in drug courts. It reviews effective medications, including methadone, buprenorphine, and naltrexone. The guide also provides strategies to increase the use of MAT in drug court programs.

Publication ID: SMA14-4736
Published:

This guide addresses specific treatment needs of adult men living with substance use disorders. It reviews gender-specific research and best practices, such as common patterns of substance use among men and specific treatment issues and strategies.

Publication ID: SMA13-4773
Published:

This handbook reviews Medicaid and its role in financing services and treatment for mental illness and substance use disorders. It discusses services included in state Medicaid plans and other factors related to Medicaid, such as reimbursement.

Publication ID: SYNAR-12
Published:

This report presents findings on compliance with the Synar Amendment aimed at decreasing youth access to tobacco. It reviews progress in enforcing state youth tobacco access laws and reducing the percentage of retailers selling tobacco products to minors.